Literature DB >> 24882150

The emerging role of soluble HLA-G in the control of chemotaxis.

Fabio Morandi1, Nathalie Rouas-Freiss2, Vito Pistoia3.   

Abstract

HLA-G is an immunosuppressive molecule, that impairs the function of different immune cell populations, both in physiological and pathological conditions. Here, we have analyzed data obtained by our group and others regarding sHLA-G concentration in plasma from patients with different diseases. Next, we have summarized novel data regarding the impairment of chemotaxis of different immune effector cells mediated by sHLA-G. Finally, we have discussed the impact of this function on the immune response during cancer, viral infection, autoimmunity, and on B cell differentiation in secondary lymphoid organs. In conclusion, we have delineated a role of sHLA-G in the control of chemotaxis of immune effector cells, that may be relevant to modulate immune responses in different settings.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemokine receptors; Chemotaxis; HLA-G

Mesh:

Substances:

Year:  2014        PMID: 24882150     DOI: 10.1016/j.cytogfr.2014.04.004

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  12 in total

1.  Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Mol Med       Date:  2015-08-24       Impact factor: 6.354

2.  HLA-G-ILT2 interaction contributes to suppression of bone marrow B cell proliferation in acquired aplastic anemia.

Authors:  Yuan-Xin Sun; Qi Feng; Shu-Wen Wang; Xin Li; Zi Sheng; Jun Peng
Journal:  Ann Hematol       Date:  2022-01-18       Impact factor: 3.673

3.  Evolution of the levels of human leukocyte antigen G (HLA-G) in Beninese infant during the first year of life in a malaria endemic area: using latent class analysis.

Authors:  Tania C d'Almeida; Ibrahim Sadissou; Gilles Cottrell; Rachida Tahar; Philippe Moreau; Benoit Favier; Kabirou Moutairou; Eduardo A Donadi; Achille Massougbodji; Nathalie Rouass-Freiss; David Courtin; André Garcia
Journal:  Malar J       Date:  2016-02-09       Impact factor: 2.979

Review 4.  Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells.

Authors:  Thomas Menter; Alexandar Tzankov
Journal:  Front Oncol       Date:  2018-03-07       Impact factor: 6.244

Review 5.  Role of Human Leukocyte Antigens at the Feto-Maternal Interface in Normal and Pathological Pregnancy: An Update.

Authors:  Chiara Tersigni; Federica Meli; Caterina Neri; Azzurra Iacoangeli; Rita Franco; Antonio Lanzone; Giovanni Scambia; Nicoletta Di Simone
Journal:  Int J Mol Sci       Date:  2020-07-04       Impact factor: 5.923

Review 6.  HLA-G: A New Immune Checkpoint in Cancer?

Authors:  Daniëlle Krijgsman; Jessica Roelands; Wouter Hendrickx; Davide Bedognetti; Peter J K Kuppen
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

7.  Clinical Significance of Potential Unidentified HLA-G Isoforms Without α1 Domain but Containing Intron 4 in Colorectal Cancer Patients.

Authors:  Aifen Lin; Xia Zhang; Rui-Li Zhang; Jian-Gang Zhang; Wen-Jun Zhou; Wei-Hua Yan
Journal:  Front Oncol       Date:  2018-09-04       Impact factor: 6.244

Review 8.  Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Front Immunol       Date:  2018-09-27       Impact factor: 7.561

Review 9.  The Role of NK Cells in EBV Infection and EBV-Associated NPC.

Authors:  Yi Tian Png; Audrey Zhi Yi Yang; Mei Ying Lee; Magdalene Jahn May Chua; Chwee Ming Lim
Journal:  Viruses       Date:  2021-02-15       Impact factor: 5.048

Review 10.  Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases.

Authors:  Fabio Morandi; Roberta Rizzo; Enrico Fainardi; Nathalie Rouas-Freiss; Vito Pistoia
Journal:  J Immunol Res       Date:  2016-08-29       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.